SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001078782-16-003347
Filing Date
2016-08-25
Accepted
2016-08-25 15:20:21
Documents
57
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A AMENDED QUARTERLY REPORT f10qa063016_10qz.htm 10-Q/A 42895
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10qa063016_ex31z1.htm EX-31.1 6132
3 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10qa063016_ex32z1.htm EX-32.1 2819
  Complete submission text file 0001078782-16-003347.txt   1709768

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20160630_cal.xml EX-101.CAL 9134
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20160630_def.xml EX-101.DEF 25767
6 XBRL INSTANCE DOCUMENT axim-20160630.xml EX-101.INS 203782
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20160630_lab.xml EX-101.LAB 252860
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20160630_pre.xml EX-101.PRE 149367
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20160630.xsd EX-101.SCH 63646
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 161851422
SIC: 2834 Pharmaceutical Preparations